|
Volumn 1530, Issue 2-3, 2001, Pages 134-145
|
Liposomes as sustained release system for human interferon-γ: Biopharmaceutical aspects
|
Author keywords
Biodistribution; Drug delivery system; Interferon ; Liposome; Subcutaneous administration
|
Indexed keywords
CYTOKINE;
IODINE 125;
LIPOSOME;
PHOSPHOLIPID;
RECOMBINANT GAMMA INTERFERON;
TUMOR NECROSIS FACTOR ALPHA;
ANIMAL EXPERIMENT;
ARTICLE;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DRUG DELIVERY SYSTEM;
DRUG DISTRIBUTION;
ENCAPSULATION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
FEMALE;
HUMAN;
HUMAN CELL;
IONIC STRENGTH;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
SUSTAINED RELEASE PREPARATION;
ADJUVANTS, IMMUNOLOGIC;
ANIMALS;
DELAYED-ACTION PREPARATIONS;
FEMALE;
HUMANS;
INJECTIONS, SUBCUTANEOUS;
INTERFERON TYPE II;
IODINE RADIOISOTOPES;
LIPOSOMES;
MICE;
MICE, INBRED C57BL;
MONOCYTES;
PHOSPHOLIPIDS;
RECOMBINANT PROTEINS;
SURFACE PROPERTIES;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0035952340
PISSN: 13881981
EISSN: None
Source Type: Journal
DOI: 10.1016/S1388-1981(00)00174-8 Document Type: Article |
Times cited : (72)
|
References (31)
|